[Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)]
- PMID: 3127975
[Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)]
Similar articles
-
Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.N Engl J Med. 1988 Sep 1;319(9):548-55. doi: 10.1056/NEJM198809013190905. N Engl J Med. 1988. PMID: 3136331 Clinical Trial.
-
The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study.Acta Neurol Scand. 1985 Feb;71(2):164-7. doi: 10.1111/j.1600-0404.1985.tb03182.x. Acta Neurol Scand. 1985. PMID: 3920861 Clinical Trial.
-
Aldose reductase inhibition for diabetic neuropathy.Lancet. 1983 Oct 22;2(8356):969. Lancet. 1983. PMID: 6138528 Clinical Trial. No abstract available.
-
[Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].Nihon Rinsho. 1987 Dec;45(12):3010-27. Nihon Rinsho. 1987. PMID: 3128677 Review. Japanese. No abstract available.
-
Review of myo-inositol and sorbinil studies.Clin Physiol. 1985;5 Suppl 5:90-3. Clin Physiol. 1985. PMID: 3938689 Review. No abstract available.
Cited by
-
Aldose reductase inhibitors for the treatment of diabetic polyneuropathy.Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD004572. doi: 10.1002/14651858.CD004572.pub2. Cochrane Database Syst Rev. 2007. PMID: 17943821 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical